Regional webinar series (please note this event is in French).

Cancer is the second leading cause of death worldwide. Early cancer detection is one of the most impactful elements on survival rate, hence the importance of precise screening tools such as Liquid Biopsies for a first diagnosis or during patient monitoring. At Nonacus, we enable decentralized, cost effective and cutting-edge cancer genomics and democratize early cancer detection and monitoring globally. We facilitate this by developing non-invasive highly precise solutions that will empower clinicians and help patients fighting cancer more efficiently.

This webinar will discuss the opportunities and challenges of Liquid biopsy
in Precision Oncology, how Nonacus’ innovative solutions aim at changing the standards in Precision Oncology, with examples focusing on early bladder cancer and pancreatic cancer detection.

For further details please email elodie.desmaris@nonacus.com or visit www.nonacus.com.

00:00-Intro
04:12-Cancer and importance of early detection (Dr. G. Maes)
06:20-Liquid Biopsy as a powerful tool in precision oncology
10:13-How can Nonacus help you in clinical oncology?
15:54-Nonacus’ first full clinical solution for bladder cancer detection: GALEAS® Bladder
27:32-Nonacus custom panel
30:33-Application of Nonacus’ customized comprehensive gene panel for pancreatic cancer (Pr. A. Harlé)
54:39-Q&A

свернуть